tatmeen uae traceability system

[Blog] Tatmeen Traceability System – UAE’s Track & Trace solution for Pharmaceuticals

UAE`s Ministry of Health and Prevention (MOHAP) announced the establishment of the first traceability solution for the pharma industry – the Tatmeen.

 

 

 

 

 

In the middle of 2021, in Ministerial Decree No. 73, the Ministry of Health and Prevention (MOHAP) announced the establishment of the first traceability solution for the pharma industry – the Tatmeen platform. MOHAP, in partnership with Dubai Health Authority (DHA) and EVOTEQ, is developing the GS1-based platform, enabling the traceability of pharma products across the supply chain.

 

The Tatmeen`s benefits are the familiar ones – fight drug counterfeiting, ensure secure healthcare, enhance visibility, real-time monitoring across the supply chain, recall management.

 

Objectives

 

Product Security

  • Ensure traceability; detect counterfeited drugs; avoid reimbursement fraud; fast product recalls and withdrawals

 

Patient Safety

  • Minimize the risk of errors; prediction

 

Supply Chain Management

  • Forecast shortages; real-time and secure exchange of data

 

 

Regulatory requirements

 

Regarding serialization requirements, the product must be labelled with four data points in a GS1 Data Matrix code:

GTIN (Global Trade Item Number)

Randomized serial number – up to 20 characters

Expiry date – YYMMDD format

Batch/ lot number

 

As for aggregation, the manufacturer is responsible for labelling all logistic units with GS1-128 barcodes encoded with SSCC (Serial Shipping Container Code).

 

 

The exemptions

 

Products that are exempt from serialization are:

  • Free samples of pharmaceutical products;
  • Pharmaceutical products imported for personal use only;
  • Medical devices and supplies; and
  • GSL products.

 

 

Timeline

 

13 December 2021– the deadline of the 6-month grace period, after which all pharmaceutical products imported into the UAE must comply with the decree by applying a 2D matrix barcode and  human-readable format,  by following GS1 standards;

 

13 December 2022 – deadline of the 18 months period  for serialization reporting and onboarding onto Tatmeen

 

13 December 2022 – deadline for registration with a GS1 Global Location Number (GLN) of all sites that are licensed to dispense medicines in the UAE

 


Sources:

https://tatmeen.ae/

https://tatmeen.ae/pdfs/Technical%20Guide%20-%20MAH%20v1.0%20-%20English.pdf

https://tatmeen.ae/pdfs/MOHAP%20SERIALIZATION%20GUIDE%20V1.0%20EN%20FINAL1.pdf

By continuing to use the site, you agree to the terms of our Privacy and Cookies Policy and the use of cookies. Privacy and Cookies Policy

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close